Description: Stale portfolio got your sales down? In this session, you'll learn about the latest and greatest in product development trends and innovations which you can use to refresh and revitalize your products. At the conclusion of this session, attendees will have a better understanding on market trends in product development as well as leading innovations.

Description: Many new and innovative companies are leveraging technology to improve the effectiveness of the care provided to patients. They are employing better tools to identify patients who can benefit from specific programs that best meet the patient's need. They are also dramatically increasing the use of these programs by guiding plan members through the maze of offerings to match them with the programs that will be most beneficial to them. Employers are making these third party programs available to their members and Medicare Plans are using these new tools to identify emerging health risks for early intervention and more accurate risk scoring. This session will explore some examples of these programs, how they are being effectively integrated into the operations of health plans and how the results of these programs are being measured.The speakers will be:Raj Behal, MD, MPH,Chief Quality Officer, One Medical. Raj leads the quality and safety, value and innovation, and data science teams at One Medical. One Medical is changing the way primary care is delivered with a concierge approach with technology seamlessly woven into their offering. This includes booking appointments on line, virtual face to face care, accessible medical records and health reminders.Mylea Charval,Ph.D., CEO and Founder, Savonix. Savonix is a next generation cognitive assessment platform that brings clinical, evidence-based, and all mobile digital assessment of cognitive and emotional function. These capabilities are critical for early identification of the onset of dementia and for the proper risk assessment of seniors enrolled in Medicare Advantage Plans.Ed Cymerys, FSA, Advisor. Ed will serve as moderator. Over the last six years Ed has served as an advisor to a number of early stage technology companies looking to improve the way health benefits are being delivered.Dave Sotelo, FSA, MAAA, Actuarial Manager, Collective Health, Inc. Collective Health is an integrated solution that allows self-funded employers to administer their health plans, control costs, and take care of their people -- all in one place. They have effectively integrated more than 70 distinct third party solutions for self-funded employers and are rigorously assessing the impact of these programs

Description: Mr. Zhao stressed that the CBRC adhered to the national principles of risk-oriented, problem-oriented, and openness-oriented, and remained fully mobilized and united to the benefit of the insurance industry. The CBRC overcame the difficulties of the epidemic and pushed forward the C-ROSS Phase II project.

Description: Manulife has been preparing on the system development for IFRS17 implementation since 2018. Manulife will start official parallel run in 2022. The purpose of this presentation was to share the valuable system development experience gained over the past 3 years. The practical cases would be shared, to discuss key areas including projection, implementation and expectation. After IFRS17 implementation, on top of being data experts, the future actuary will play an more active role in corporation analysis and strategy planning.

Description: The presenters will discuss the range of draft repeal/repair/replace legislation proposed to date, the elements most likely to be included in the final law, and possible temporary and transitional measures to be taken. They will share their findings regarding the impact on the industry of these changes using the most up to date data and modeling available.

Description: These products effectively provide policyholders access to an equity index with an option pass-through. This new direction blurs the line between more traditional variable annuity and fixed indexed annuity products. This session will discuss these and other similar product innovations, including some interesting regulatory, accounting, and risk management considerations.

Description: The presenter will share his opinion on the major and minor cycle of the global and China economy. He believes that the recovery of the major cycle depends on the resonance of politics between China and the United States, as well as reform. As the minor cycle is V-type, the weak recovery depends on policy and price increase. The liquidity regulation and the growth advance together. The economic cycle is stabilizing, monetary policy is tightening the margin and the importance of the regulation is increasing. But the increase of the economy is critical to risk controlling.

Description: General Introduction of Block Chain•This session will introduce the definition, history and current status of block chain, as well as the necessities of its development.Incorporating Block Chain into the Insurance Industry•Presenters will illustrate the significant roles, unique features and future prospects of block chain’s application in an insurance company’s operation.Actuarial Application in Block Chain Development•Experts will demonstrate what roles actuaries play and how actuarial techniques can be optimized in block chain development.The Achievements of Block Chain’s Application in Sunshine Insurance Group•This session will discuss the implementation process, as well as the remarkable achievements of block chain’s application in Sunshine Insurance Group.

Description: Companies can implement VM-20 as early as 2017. While there have been research and educational materials produced to help actuaries and others better understand the implications and implementation of the new requirements from a financial reporting perspective, little has been developed emphasizing the product development actuary perspective. This SOA research project examines the impact of VM-20 from a product development actuarial perspective. The research will help actuaries and others enhance current practices to optimize pricing and product development activities within a VM-20 framework as well as enhance intracompany communication and efficiencies related to VM-20. This session is a follow-up to the session at last year’s symposium and will focus on Phase 2 of the research project.

Description: The session will talk about Management expectation and key development areas of Big Data, overview of big data application in the life insurance industry.